Quantitation of 10 antibiotics in plasma: Sulfosalicylic acid combined with 2D-LC-MS/MS is a robust assay for beta-lactam therapeutic drug monitoring.

[1]  F. Pea,et al.  Expert clinical pharmacological advice may make an antimicrobial TDM program for emerging candidates more clinically useful in tailoring therapy of critically ill patients , 2022, Critical Care.

[2]  N. Mano,et al.  Cutting edge LC-MS/MS applications in clinical mass spectrometry -Focusing on analysis of drugs and metabolites. , 2022, Biomedical chromatography : BMC.

[3]  F. Kobarfard,et al.  Overview, consequences, and strategies for overcoming matrix effects in LC-MS analysis: a critical review. , 2021, The Analyst.

[4]  G. Hopfgartner,et al.  Mass spectrometry based high-throughput bioanalysis of low molecular weight compounds: are we ready to support personalized medicine? , 2021, Analytical and Bioanalytical Chemistry.

[5]  C. Peloquin,et al.  Early therapeutic monitoring of β-lactams and associated therapy outcomes in critically ill patients. , 2020, The Journal of antimicrobial chemotherapy.

[6]  A. Petruczynik,et al.  Review of Chromatographic Methods Coupled with Modern Detection Techniques Applied in the Therapeutic Drugs Monitoring (TDM) , 2020, Molecules.

[7]  T. Buclin,et al.  Validation and clinical application of a multiplex high performance liquid chromatography - tandem mass spectrometry assay for the monitoring of plasma concentrations of 12 antibiotics in patients with severe bacterial infections. , 2020, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[8]  D. Marriott,et al.  Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper# , 2020, Intensive Care Medicine.

[9]  Christoph Seger,et al.  After another decade: LC-MS/MS became routine in clinical diagnostics. , 2020, Clinical biochemistry.

[10]  D. Marriott,et al.  A retrospective study to determine the cefepime-induced neurotoxicity threshold in hospitalized patients. , 2019, The Journal of antimicrobial chemotherapy.

[11]  S. Leroux,et al.  UPLC/MS/MS assay for the simultaneous determination of seven antibiotics in human serum-Application to pediatric studies. , 2019, Journal of pharmaceutical and biomedical analysis.

[12]  F. Lemaitre,et al.  Optimization of the treatment with beta-lactam antibiotics in critically ill patients—guidelines from the French Society of Pharmacology and Therapeutics (Société Française de Pharmacologie et Thérapeutique—SFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Société Française d’ , 2019, Critical Care.

[13]  Michał Kaza,et al.  Bioanalytical method validation: new FDA guidance vs. EMA guideline. Better or worse? , 2019, Journal of pharmaceutical and biomedical analysis.

[14]  M. Doogue,et al.  Short communication: Pre-analytical stability of piperacillin, tazobactam, meropenem and ceftazidime in plasma and whole blood using LC-MS/MS. , 2019, Therapeutic drug monitoring.

[15]  D. Seder,et al.  Cefepime-induced neurotoxicity: a systematic review , 2017, Critical Care.

[16]  M. Weigand,et al.  Therapeutic drug monitoring of beta‐lactam antibiotics – Influence of sample stability on the analysis of piperacillin, meropenem, ceftazidime and flucloxacillin by HPLC‐UV , 2017, Journal of pharmaceutical and biomedical analysis.

[17]  P. Lescuyer,et al.  Cefepime plasma concentrations and clinical toxicity: a retrospective cohort study. , 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[18]  Juok Kim,et al.  A reference measurement procedure for amino acids in blood using isotope dilution ultra-performance liquid chromatography-tandem mass spectrometry. , 2017, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[19]  Jing Zhang,et al.  Rapid and Simultaneous Quantitation of Amoxicillin and Clavulanic Acid in Human Plasma and Urine by Ultra-Performance Liquid Chromatography Tandem Mass Spectrometry and Its Application to a Pharmacokinetic Study. , 2016, Analytical sciences : the international journal of the Japan Society for Analytical Chemistry.

[20]  A. Hulin,et al.  Simultaneous Determination of Eight β-Lactam Antibiotics, Amoxicillin, Cefazolin, Cefepime, Cefotaxime, Ceftazidime, Cloxacillin, Oxacillin, and Piperacillin, in Human Plasma by Using Ultra-High-Performance Liquid Chromatography with Ultraviolet Detection , 2016, Antimicrobial Agents and Chemotherapy.

[21]  S. Harbarth,et al.  Therapeutic drug monitoring of the β-lactam antibiotics: what is the evidence and which patients should we be using it for? , 2015, The Journal of antimicrobial chemotherapy.

[22]  Mengqi Cui,et al.  5-sulfosalicylic Acid Dihydrate-Based Pretreatment for the Modification of Enzyme-Linked Immunoassay of Fluoroquinolones in Fishery Products , 2015, Journal of immunoassay & immunochemistry.

[23]  E. Varesio,et al.  Generic on-line solid phase extraction sample preparation strategies for the analysis of drugs in biological matrices by LC-MS/MS. , 2015, Journal of pharmaceutical and biomedical analysis.

[24]  J. Rello,et al.  Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients , 2014, Intensive Care Medicine.

[25]  M. Roberts,et al.  Simultaneous determination of seven β-lactam antibiotics in human plasma for therapeutic drug monitoring and pharmacokinetic studies. , 2014, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[26]  J. Rello,et al.  DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients? , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  B. Buszewski,et al.  Pharmacokinetic study of amoxicillin in human plasma by solid-phase microextraction followed by high-performance liquid chromatography-triple quadrupole mass spectrometry. , 2014, Biomedical chromatography : BMC.

[28]  O. Laprévote,et al.  Rugged and accurate quantitation of colchicine in human plasma to support colchicine poisoning monitoring by using turbulent-flow LC-MS/MS analysis. , 2013, Bioanalysis.

[29]  Philip Timmerman,et al.  The European Bioanalysis Forum community's evaluation, interpretation and implementation of the European Medicines Agency guideline on Bioanalytical Method Validation. , 2013, Bioanalysis.

[30]  J. X. de Araújo-Júnior,et al.  Short-term stability studies of ampicillin and cephalexin in aqueous solution and human plasma: Application of least squares method in Arrhenius equation. , 2013, Journal of pharmaceutical and biomedical analysis.

[31]  C. Michelet,et al.  Simultaneous Determination of 12 β-Lactam Antibiotics in Human Plasma by High-Performance Liquid Chromatography with UV Detection: Application to Therapeutic Drug Monitoring , 2011, Antimicrobial Agents and Chemotherapy.

[32]  R. Powers,et al.  Simple and rapid quantitative high-performance liquid chromatographic analysis of plasma amino acids. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[33]  J. Li,et al.  High-performance liquid chromatographic method for simple and rapid determination of linezolid in human plasma. , 2006, Biomedical chromatography : BMC.

[34]  V. Samanidou,et al.  Development of a validated HPLC method for the determination of four penicillin antibiotics in pharmaceuticals and human biological fluids. , 2006, Journal of separation science.

[35]  K. Wood,et al.  Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock* , 2006, Critical care medicine.

[36]  C. Sprung,et al.  Sepsis in European intensive care units: Results of the SOAP study* , 2006, Critical care medicine.

[37]  J. Pedraz,et al.  Determination of ceftazidime and cefepime in plasma and dialysate-ultrafiltrate from patients undergoing continuous veno-venous hemodiafiltration by HPLC. , 2005, Journal of pharmaceutical and biomedical analysis.

[38]  J. Pedraz,et al.  Quantitation and stability of piperacillin and tazobactam in plasma and ultrafiltrate from patients undergoing continuous venovenous hemofiltration by HPLC. , 2005, Biomedical chromatography : BMC.

[39]  G. Hopfgartner,et al.  Determination of talinolol in human plasma using automated on-line solid phase extraction combined with atmospheric pressure chemical ionization tandem mass spectrometry. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[40]  B. Matuszewski,et al.  Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. , 2003, Analytical chemistry.

[41]  B. Incledon,et al.  Optimization of protein precipitation based upon effectiveness of protein removal and ionization effect in liquid chromatography-tandem mass spectrometry. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[42]  Claude D Martin,et al.  Empirical antimicrobial therapy of septic shock patients: Adequacy and impact on the outcome* , 2003, Critical care medicine.

[43]  G. Hopfgartner,et al.  Quantitative high-throughput analysis of drugs in biological matrices by mass spectrometry. , 2003, Mass spectrometry reviews.

[44]  Marin H Kollef,et al.  Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. , 2002, Chest.

[45]  Timothy Olah,et al.  Mechanistic investigation of ionization suppression in electrospray ionization , 2000, Journal of the American Society for Mass Spectrometry.

[46]  M. Lee,et al.  LC/MS applications in drug development. , 2002, Mass spectrometry reviews.

[47]  G. Hopfgartner,et al.  Column-switching high-performance liquid chromatography combined with ionspray tandem mass spectrometry for the simultaneous determination of the platelet inhibitor Ro 44-3888 and its pro-drug and precursor metabolite in plasma. , 1997, Journal of mass spectrometry : JMS.

[48]  V. Spiehler,et al.  Whole blood deproteinization for drug screening using automatic pipettors. , 1992, Journal of analytical toxicology.

[49]  R. Christenson,et al.  Digoxin-like immunoreactivity eliminated from serum by centrifugal ultrafiltration before fluorescence polarization immunoassay of digoxin. , 1987, Clinical chemistry.

[50]  K. Gruhn,et al.  Vergleichende Untersuchungen zum Präzipitationsverhalten verschiedener Proteinfällungsmittel in Organen und Geweben , 1985 .